How AI & Wearables Are Shaping The Future of Healthcare with Dr. Ami Bhatt

This is not your grandmother's FDA, if you will. It has been progressively changing and understanding that digital health has changed things for us. Wearables are, in fact, the only way we are going to achieve population health goals. We can't achieve population health population health goals. We can't achieve population health without the use of wearables. How do you take that wearable daughter and make it relevant to your health care provider, right? And how does a health care provider understand that? The level of science that you create here at Blue, it's real science. It's not consumerism. It's patient agency. And it's really my job and my colleague's job to teach our clinicians that and to get them to accept that culture change. I want an infrastructure to enable this kind of care in the communities where people live using their data. How do I do it safely and with good guardrails? And that's kind of what we're about. Hi, everybody. I'm Emily Capitalupo, WOOP senior vice president of research algorithms and data. And today, I am joined by the incredible doctor Ami Bhatt. Thank you so much for having me. Thank you so much for being here. Doctor Bhatt is a cardiologist. She is the chief innovation officer at the American College of Cardiology as well as the chair of digital health at the FDA. Doctor. Bhatt has an incredibly interesting perspective because she sees cardiology both from a policy and regulatory side as well as previously being a practicing cardiologist, and so she blends both of those worlds in a really fascinating way, and I'm very excited to have her on the podcast today. So so I wanna start off because you are the very first chair of digital health at the FDA, so a new role Mhmm. Which is a really cool sign of the FDA being with the times and understanding that this AI revolution is coming and all of that. And so what is this new role? What is this new department, and what does it say about what the FDA is thinking about and doing? This is not your grandmother's FDA, if you will. It has been progressively changing and understanding that digital health has changed things for us. And looking at software as a medical device was the first time that the FDA really started to kind of speed up in a safe and efficient way the process of getting access to these types of technologies to our patients. And that's the most important part of this. Whether we're talking about diagnostic screening or understanding algorithms, there is so much we have to offer, and we really need a streamlined way to get there. And so it's before the digital health advisory committee, which is what I chair, even started that the FDA started becoming aware of the need for us to really modernize our approach. The digital health advisory committee itself, we are a group of individuals that are here …